Gabriela S. Hobbs, MD, clinical director of the Leukemia Service and assistant in medicine at Massachusetts General Hospital, shares her advice for a community oncologist treating a patient with chronic myeloid leukemia.
Gabriela S. Hobbs, MD, clinical director of the Leukemia Service and assistant in medicine at Massachusetts General Hospital, shares her advice for a community oncologist treating a patient with chronic myeloid leukemia (CML).
Hobbs says it is important to understand that while patients with CML seem fine, they are still sick and require the same amount of effort as other patients. These patients can have a near-normal life expectancy, but they still need to be monitored according to the recommendations from the NCCN or ELN Guidelines.
Cretostimogene Grenadenorepvec Shows High CR Rate in BCG-Unresponsive NMIBC
July 17th 2024Mark D. Tyson, II, MD, MPH, discussed treatment with cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ and data from the BOND-003 trial.
Read More